To attend virtually, please click the following link: Zoom:https://baystatehealth.zoom.us/j/92482071711?pwd=kO6v0xJ0OqvFBbmCNbx1X36qY4KBLu.1&from=addon

Objectives

After participating in this educational activity, attendees should be able to:

  1. Understand the different WHO classifications of PH and their clinical implications.
  2. Differentiate Between Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Due to Left Heart Disease (PH-LHD)
  3. Learn how to assess disease severity in PAH using risk stratification models 
  4. Identify When to Refer Patients to a PH Specialist

Presenter(s): 
Sophia Airhart, MD
Medical Director of Pulmonary Hypertension and Regional Heart Failure
Baystate Health

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Sophia Airhart, MD Speaker

Independent contractor for Alleviant
Consultant, United Therapies

No
Session date: 
02/25/2025 - 7:30am to 8:30am EST
Location: 
Baystate Medical Center
759 Chestnut Street
MM6 Conference Room
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.